{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:29:39Z","timestamp":1787495379350,"version":"build-2736575974"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00277-023-05234-1","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T11:04:16Z","timestamp":1681902256000},"page":"1307-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-9669","authenticated-orcid":false,"given":"Mohammad","family":"Sayyadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-9987","authenticated-orcid":false,"given":"Saeed","family":"Hassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3812-5357","authenticated-orcid":false,"given":"Mahmood","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-9319","authenticated-orcid":false,"given":"Akbar","family":"Dorgalaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"issue":"1","key":"5234_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00277-020-04305-x","volume":"100","author":"H-c Luo","year":"2021","unstructured":"Luo H-c, You C-y, Lu S-w, Fu Y-q (2021) Characteristics of coagulation alteration in patients with COVID-19. Ann Hematol 100(1):45\u201352. https:\/\/doi.org\/10.1007\/s00277-020-04305-x","journal-title":"Ann Hematol"},{"issue":"10","key":"5234_CR2","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00277-020-04216-x","volume":"99","author":"A Hanif","year":"2020","unstructured":"Hanif A, Khan S, Mantri N et al (2020) Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience. Ann Hematol 99(10):2323\u20132328. https:\/\/doi.org\/10.1007\/s00277-020-04216-x","journal-title":"Ann Hematol"},{"issue":"7","key":"5234_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/s2213-2600(20)30243-5","volume":"8","author":"SE Fox","year":"2020","unstructured":"Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS (2020) Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 8(7):681\u2013686. https:\/\/doi.org\/10.1016\/s2213-2600(20)30243-5","journal-title":"Lancet Respir Med"},{"issue":"7","key":"5234_CR4","doi-asserted-by":"publisher","first-page":"e6011","DOI":"10.1002\/ccr3.6011","volume":"10","author":"R Sarmadian","year":"2022","unstructured":"Sarmadian R, Ghasemikhah R, Sarmadian H, Khosravi M, Hassani S (2022) Post-COVID-19 splenic infarction in a patient with chronic atrial fibrillation: a case report. Clin Case Rep 10(7):e6011. https:\/\/doi.org\/10.1002\/ccr3.6011","journal-title":"Clin Case Rep"},{"issue":"1","key":"5234_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.26355\/eurrev_202101_24423","volume":"25","author":"M Sayyadi","year":"2021","unstructured":"Sayyadi M, Khosravi M, Ghaznavi-Rad E (2021) Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019. Eur Rev Med Pharmacol Sci 25(1):518\u2013522. https:\/\/doi.org\/10.26355\/eurrev_202101_24423","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"5234_CR6","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s00277-020-04182-4","volume":"99","author":"A Allegra","year":"2020","unstructured":"Allegra A, Innao V, Allegra AG, Musolino C (2020) Coagulopathy and thromboembolic events in patients withSARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol 99(9):1953\u20131965. https:\/\/doi.org\/10.1007\/s00277-020-04182-4","journal-title":"Ann Hematol"},{"issue":"4","key":"5234_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tmrv.2019.08.004","volume":"33","author":"S Dzik","year":"2019","unstructured":"Dzik S (2019) Complement and coagulation: cross talk through time. Transfus Med Rev 33(4):199\u2013206. https:\/\/doi.org\/10.1016\/j.tmrv.2019.08.004","journal-title":"Transfus Med Rev"},{"issue":"2","key":"5234_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","volume":"22","author":"B Afzali","year":"2022","unstructured":"Afzali B, Noris M (2022) The state of complement in COVID-19. Nat Rev Immunol 22(2):77\u201384. https:\/\/doi.org\/10.1038\/s41577-021-00665-1","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"5234_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, Vecchie A, Dagna L et al (2021) Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 21(5):319\u2013329. https:\/\/doi.org\/10.1038\/s41577-021-00536-9","journal-title":"Nat Rev Immunol"},{"key":"5234_CR10","doi-asserted-by":"publisher","unstructured":"Rad F, Dabbagh A, Dorgalaleh A, Biswas A (2021) The relationship between inflammatory cytokines and coagulopathy in patients with COVID-19. J Clin Med 10(9). https:\/\/doi.org\/10.3390\/jcm10092020","DOI":"10.3390\/jcm10092020"},{"issue":"01","key":"5234_CR11","first-page":"19","volume":"48","author":"M Bahraini","year":"2021","unstructured":"Bahraini M, Dorgalaleh A (2021) The impact of SARS-CoV-2 infection on blood coagulation and fibrinolytic pathways: a review of prothrombotic changes caused by COVID-19. Semin Thromb Hemost 48(01):19\u201330","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"5234_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1055\/s-0040-1713434","volume":"46","author":"A Dorgalaleh","year":"2020","unstructured":"Dorgalaleh A (2020) Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost 46(07):815\u2013818","journal-title":"Semin Thromb Hemost"},{"key":"5234_CR13","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","volume":"46","author":"Y Sang","year":"2021","unstructured":"Sang Y, Roest M, de Laat B, de Groot PG, Huskens D (2021) Interplay between platelets and coagulation. Blood Rev 46:100733. https:\/\/doi.org\/10.1016\/j.blre.2020.100733","journal-title":"Blood Rev"},{"issue":"1","key":"5234_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang S, Liu Y, Wang X et al (2020) SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol 13(1):120. https:\/\/doi.org\/10.1186\/s13045-020-00954-7","journal-title":"J Hematol Oncol"},{"issue":"11","key":"5234_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood.2020007214","volume":"136","author":"BK Manne","year":"2020","unstructured":"Manne BK, Denorme F, Middleton EA et al (2020) Platelet gene expression and function in patients with COVID-19. Blood 136(11):1317\u20131329. https:\/\/doi.org\/10.1182\/blood.2020007214","journal-title":"Blood"},{"issue":"11","key":"5234_CR16","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/circresaha.120.317703","volume":"127","author":"Y Zaid","year":"2020","unstructured":"Zaid Y, Puhm F, Allaeys I et al (2020) Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res 127(11):1404\u20131418. https:\/\/doi.org\/10.1161\/circresaha.120.317703","journal-title":"Circ Res"},{"issue":"12","key":"5234_CR17","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1161\/atvbaha.120.315175","volume":"40","author":"F Taus","year":"2020","unstructured":"Taus F, Salvagno G, Can\u00e8 S et al (2020) Platelets promote thromboinflammation in SARS-CoV-2 pneumonia. Arterioscler Thromb Vasc Biol 40(12):2975\u20132989. https:\/\/doi.org\/10.1161\/atvbaha.120.315175","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5234_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/mbc.0000000000000996","volume":"32","author":"MT Calderon-Lopez","year":"2021","unstructured":"Calderon-Lopez MT, Garcia-Leon N, Gomez-Arevalillo S, Martin-Serrano P, Matilla-Garcia A (2021) Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors. Blood Coagul Fibrinolysis 32(1):44\u201349. https:\/\/doi.org\/10.1097\/mbc.0000000000000996","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"11","key":"5234_CR19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood.2020007252","volume":"136","author":"ED Hottz","year":"2020","unstructured":"Hottz ED, Azevedo-Quintanilha IG, Palhinha L et al (2020) Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood 136(11):1330\u20131341. https:\/\/doi.org\/10.1182\/blood.2020007252","journal-title":"Blood"},{"issue":"12","key":"5234_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/circulationaha.120.048488","volume":"142","author":"L Nicolai","year":"2020","unstructured":"Nicolai L, Leunig A, Brambs S et al (2020) Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation 142(12):1176\u20131189. https:\/\/doi.org\/10.1161\/circulationaha.120.048488","journal-title":"Circulation"},{"key":"5234_CR21","doi-asserted-by":"publisher","first-page":"104950","DOI":"10.1016\/j.phrs.2020.104950","volume":"158","author":"M Viecca","year":"2020","unstructured":"Viecca M, Radovanovic D, Forleo GB, Santus P (2020) Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res 158:104950. https:\/\/doi.org\/10.1016\/j.phrs.2020.104950","journal-title":"Pharmacol Res"},{"issue":"6","key":"5234_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","volume":"99","author":"P Xu","year":"2020","unstructured":"Xu P, Zhou Q, Xu J (2020) Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol 99(6):1205\u20131208. https:\/\/doi.org\/10.1007\/s00277-020-04019-0","journal-title":"Ann Hematol"},{"key":"5234_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM (2020) Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 506:145\u2013148. https:\/\/doi.org\/10.1016\/j.cca.2020.03.022","journal-title":"Clin Chim Acta"},{"issue":"4","key":"5234_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thrombo Haemost 18(4):844\u2013847. https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thrombo Haemost"},{"issue":"10229","key":"5234_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"5234_CR26","doi-asserted-by":"crossref","unstructured":"Liu X, Zhang X, Xiao Y et al (2020) Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. MedRxiv","DOI":"10.1101\/2020.04.23.20076851"},{"issue":"17","key":"5234_CR27","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. New Eng J Med 382(17):e38. https:\/\/doi.org\/10.1056\/NEJMc2007575","journal-title":"New Eng J Med"},{"issue":"8","key":"5234_CR28","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1073\/pnas.92.8.3234","volume":"92","author":"K Kaushansky","year":"1995","unstructured":"Kaushansky K, Broudy VC, Lin N et al (1995) Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A 92(8):3234\u20133238. https:\/\/doi.org\/10.1073\/pnas.92.8.3234","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5234_CR29","doi-asserted-by":"publisher","first-page":"107995","DOI":"10.1016\/j.intimp.2021.107995","volume":"99","author":"M Delshad","year":"2021","unstructured":"Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D (2021) Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 99:107995. https:\/\/doi.org\/10.1016\/j.intimp.2021.107995","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5234_CR30","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/jci137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130(5):2620\u20132629. https:\/\/doi.org\/10.1172\/jci137244","journal-title":"J Clin Invest"},{"issue":"8","key":"5234_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/09537104.2020.1810224","volume":"31","author":"L Roncati","year":"2020","unstructured":"Roncati L, Ligabue G, Nasillo V et al (2020) A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients. Platelets 31(8):1085\u20131089. https:\/\/doi.org\/10.1080\/09537104.2020.1810224","journal-title":"Platelets"},{"issue":"2","key":"5234_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","volume":"132","author":"J Chen","year":"2018","unstructured":"Chen J, Chung DW (2018) Inflammation, von Willebrand factor, and ADAMTS13. Blood 132(2):141\u2013147. https:\/\/doi.org\/10.1182\/blood-2018-02-769000","journal-title":"Blood"},{"issue":"8","key":"5234_CR33","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/s2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua G, Pine AB, Meizlish ML et al (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7(8):e575\u2013e582. https:\/\/doi.org\/10.1016\/s2352-3026(20)30216-7","journal-title":"Lancet Haematol"},{"issue":"7","key":"5234_CR34","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P et al (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 18(7):1738\u20131742. https:\/\/doi.org\/10.1111\/jth.14850","journal-title":"J Thromb Haemost"},{"key":"5234_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijid.2021.06.051","volume":"117","author":"A Wibowo","year":"2022","unstructured":"Wibowo A, Pranata R, Lim MA, Akbara MR, Martha JW (2022) Endotheliopathy marked by high von Willebrand factor (vWF) antigen in COVID-19 is associated with poor outcome: a systematic review and meta-analysis. Int J Infect Dis 117:267\u2013273. https:\/\/doi.org\/10.1016\/j.ijid.2021.06.051","journal-title":"Int J Infect Dis"},{"issue":"10","key":"5234_CR36","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1111\/jth.14976","volume":"18","author":"S Patmore","year":"2020","unstructured":"Patmore S, Dhami SPS, O'Sullivan JM (2020) Von Willebrand factor and cancer; metastasis and coagulopathies. J Thromb Haemost 18(10):2444\u20132456. https:\/\/doi.org\/10.1111\/jth.14976","journal-title":"J Thromb Haemost"},{"issue":"4","key":"5234_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.blre.2014.04.003","volume":"28","author":"MA Sonneveld","year":"2014","unstructured":"Sonneveld MA, de Maat MP, Leebeek FW (2014) Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis. Blood Rev 28(4):167\u2013178. https:\/\/doi.org\/10.1016\/j.blre.2014.04.003","journal-title":"Blood Rev"},{"issue":"25","key":"5234_CR38","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1182\/blood-2015-05-643338","volume":"126","author":"MA Sonneveld","year":"2015","unstructured":"Sonneveld MA, de Maat MP, Portegies ML et al (2015) Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood 126(25):2739\u20132746. https:\/\/doi.org\/10.1182\/blood-2015-05-643338","journal-title":"Blood"},{"issue":"2","key":"5234_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11239-021-02457-9","volume":"52","author":"A Marco","year":"2021","unstructured":"Marco A, Marco P (2021) Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19. J Thromb Thromb 52(2):497\u2013503. https:\/\/doi.org\/10.1007\/s11239-021-02457-9","journal-title":"J Thromb Thromb"},{"issue":"4","key":"5234_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/ijlh.13476","volume":"43","author":"M Rodr\u00edguez Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez Rodr\u00edguez M, Castro Quismondo N, Zafra Torres D, Gil Alos D, Ayala R, Martinez-Lopez J (2021) Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients. Int J Lab Hematol 43(4):152\u2013155. https:\/\/doi.org\/10.1111\/ijlh.13476","journal-title":"Int J Lab Hematol"},{"key":"5234_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.thromres.2020.05.032","volume":"192","author":"R Escher","year":"2020","unstructured":"Escher R, Breakey N, Lammle B (2020) ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. Thromb Res 192:174\u2013175. https:\/\/doi.org\/10.1016\/j.thromres.2020.05.032","journal-title":"Thromb Res"},{"issue":"8","key":"5234_CR42","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1111\/jth.15409","volume":"19","author":"SE Ward","year":"2021","unstructured":"Ward SE, Fogarty H, Karampini E et al (2021) ADAMTS13 regulation of VWF multimer distribution in severe COVID-19. J Thromb Haemost 19(8):1914\u20131921. https:\/\/doi.org\/10.1111\/jth.15409","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5234_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","volume":"383","author":"L Bowles","year":"2020","unstructured":"Bowles L, Platton S, Yartey N et al (2020) Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. New Eng J Med 383(3):288\u2013290. https:\/\/doi.org\/10.1056\/NEJMc2013656","journal-title":"New Eng J Med"},{"issue":"12","key":"5234_CR44","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1055\/s-0040-1715841","volume":"120","author":"UK Katneni","year":"2020","unstructured":"Katneni UK, Alexaki A, Hunt RC et al (2020) Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus. Thromb Haemost 120(12):1668\u20131679. https:\/\/doi.org\/10.1055\/s-0040-1715841","journal-title":"Thromb Haemost"},{"issue":"15","key":"5234_CR45","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/bloodadvances.2017005629","volume":"1","author":"Q Ma","year":"2017","unstructured":"Ma Q, Jacobi PM, Emmer BT et al (2017) Genetic variants in ADAMTS13 as well as smoking are major determinants of plasma ADAMTS13 levels. Blood Adv 1(15):1037\u20131046. https:\/\/doi.org\/10.1182\/bloodadvances.2017005629","journal-title":"Blood Adv"},{"key":"5234_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.18332\/tid\/119324","volume":"18","author":"CI Vardavas","year":"2020","unstructured":"Vardavas CI, Nikitara K (2020) COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis 18:20. https:\/\/doi.org\/10.18332\/tid\/119324","journal-title":"Tob Induc Dis"},{"issue":"12","key":"5234_CR47","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","volume":"29","author":"S Butenas","year":"2009","unstructured":"Butenas S, Orfeo T, Mann KG (2009) Tissue factor in coagulation: which? where? when? Arterioscler Thromb Vasc Biol 29(12):1989\u20131996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"5234_CR48","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, O'Donnell JS, Sharif K, Emery P, Bridgewood C (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2(7):e437\u2013e445. https:\/\/doi.org\/10.1016\/S2665-9913(20)30121-1","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"5234_CR49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","volume":"19","author":"DA Gorog","year":"2022","unstructured":"Gorog DA, Storey RF, Gurbel PA et al (2022) Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol 19(7):475\u2013495. https:\/\/doi.org\/10.1038\/s41569-021-00665-7","journal-title":"Nat Rev Cardiol"},{"key":"5234_CR50","doi-asserted-by":"publisher","unstructured":"Hottz ED, Martins-Gon\u00e7alves R, Palhinha L et al (2022) Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19. Blood Adv. https:\/\/doi.org\/10.1182\/bloodadvances.2021006680","DOI":"10.1182\/bloodadvances.2021006680"},{"issue":"11","key":"5234_CR51","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros P, Mitsios A, Chrysanthopoulou A et al (2020) Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Investig 130(11):6151\u20136157. https:\/\/doi.org\/10.1172\/JCI141374","journal-title":"J Clin Investig"},{"issue":"1","key":"5234_CR52","doi-asserted-by":"publisher","first-page":"e2021045","DOI":"10.4084\/mjhid.2021.045","volume":"13","author":"N Semeraro","year":"2021","unstructured":"Semeraro N, Colucci M (2021) The prothrombotic state associated with SARS-CoV-2 infection: pathophysiological aspects. Mediterr J Hematol Infect Dis 13(1):e2021045. https:\/\/doi.org\/10.4084\/mjhid.2021.045","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"5234_CR53","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/atvbaha.120.315547","volume":"41","author":"A Rosell","year":"2021","unstructured":"Rosell A, Havervall S, von Meijenfeldt F et al (2021) Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report. Arterioscler Thromb Vasc Biol 41(2):878\u2013882. https:\/\/doi.org\/10.1161\/atvbaha.120.315547","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5234_CR54","doi-asserted-by":"publisher","unstructured":"Mast AE, Wolberg AS, Gailani D et al (2021) SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. Elife 10. https:\/\/doi.org\/10.7554\/eLife.64330","DOI":"10.7554\/eLife.64330"},{"key":"5234_CR55","doi-asserted-by":"publisher","unstructured":"FitzGerald ES, Jamieson AM (2022) Comment on SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. Elife 11. https:\/\/doi.org\/10.7554\/eLife.74268","DOI":"10.7554\/eLife.74268"},{"issue":"1","key":"5234_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.mayocp.2020.10.031","volume":"96","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Favaloro EJ, Lavie CJ, Henry BM (2021) Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc 96(1):203\u2013217. https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.031","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"5234_CR57","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/life12101605","volume":"12","author":"MC Pelle","year":"2022","unstructured":"Pelle MC, Zaffina I, Luc\u00e0 S et al (2022) Endothelial dysfunction in COVID-19: potential mechanisms and possible therapeutic options. Life 12(10):1605","journal-title":"Life"},{"issue":"5","key":"5234_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1055\/s-0039-1687906","volume":"45","author":"S Tabibian","year":"2019","unstructured":"Tabibian S, Shiravand Y, Shams M et al (2019) A comprehensive overview of coagulation factor V and congenital factor V deficiency. Semin Thromb Hemost 45(5):523\u2013543. https:\/\/doi.org\/10.1055\/s-0039-1687906","journal-title":"Semin Thromb Hemost"},{"key":"5234_CR59","doi-asserted-by":"publisher","unstructured":"Shams M, Hassani S, Dorgalaleh A, Zamani F, Ahmadi A (2023) Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients. Blood Coagul Fibrinolysis. https:\/\/doi.org\/10.1097\/mbc.0000000000001195","DOI":"10.1097\/mbc.0000000000001195"},{"issue":"12","key":"5234_CR60","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/ajh.25979","volume":"95","author":"JA Stefely","year":"2020","unstructured":"Stefely JA, Christensen BB, Gogakos T, Cone Sullivan JK, Montgomery GG, Barranco JP, Van Cott EM (2020) Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism. Am J Hematol 95(12):1522\u20131530. https:\/\/doi.org\/10.1002\/ajh.25979","journal-title":"Am J Hematol"},{"issue":"3","key":"5234_CR61","doi-asserted-by":"publisher","first-page":"103971","DOI":"10.1016\/j.isci.2022.103971","volume":"25","author":"J Wang","year":"2022","unstructured":"Wang J, Kotagiri P, Lyons PA et al (2022) Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19. iScience 25(3):103971. https:\/\/doi.org\/10.1016\/j.isci.2022.103971","journal-title":"iScience"},{"issue":"4","key":"5234_CR62","doi-asserted-by":"publisher","first-page":"E98","DOI":"10.1002\/ajh.26085","volume":"96","author":"FA von Meijenfeldt","year":"2021","unstructured":"von Meijenfeldt FA, Havervall S, Adelmeijer J et al (2021) Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality. Am J Hematol 96(4):E98\u2013E100. https:\/\/doi.org\/10.1002\/ajh.26085","journal-title":"Am J Hematol"},{"issue":"3","key":"5234_CR63","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","volume":"50","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Cao W, Jiang W et al (2020) Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis 50(3):580\u2013586. https:\/\/doi.org\/10.1007\/s11239-020-02182-9","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"5234_CR64","first-page":"216","volume":"84","author":"M Begbie","year":"2000","unstructured":"Begbie M, Notley C, Tinlin S, Sawyer L, Lillicrap D (2000) The factor VIII acute phase response requires the participation of NFkappaB and C\/EBP. Thromb Haemost 84(2):216\u2013222","journal-title":"Thromb Haemost"},{"key":"5234_CR65","doi-asserted-by":"publisher","unstructured":"Wang IE, Cooper G, Mousa SA (2021) Diagnostic approaches for COVID-19 and its associated complications. Diagnostics (Basel) 11(11). https:\/\/doi.org\/10.3390\/diagnostics11112071","DOI":"10.3390\/diagnostics11112071"},{"key":"5234_CR66","doi-asserted-by":"publisher","first-page":"718053","DOI":"10.3389\/fmed.2021.718053","volume":"8","author":"FC Ceballos","year":"2021","unstructured":"Ceballos FC, Ryan P, Blancas R et al (2021) Are reduced levels of coagulation proteins upon admission linked to COVID-19 severity and mortality? Front Med (Lausanne) 8:718053. https:\/\/doi.org\/10.3389\/fmed.2021.718053","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"5234_CR67","doi-asserted-by":"publisher","first-page":"e0252351","DOI":"10.1371\/journal.pone.0252351","volume":"16","author":"F Purroy","year":"2021","unstructured":"Purroy F, Arqu\u00e9 G (2021) Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study. PLoS One 16(6):e0252351. https:\/\/doi.org\/10.1371\/journal.pone.0252351","journal-title":"PLoS One"},{"issue":"4","key":"5234_CR68","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/ijlh.13829","volume":"44","author":"AO Al-Tamimi","year":"2022","unstructured":"Al-Tamimi AO, Yusuf AM, Jayakumar MN et al (2022) SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19. Int J Lab Hematol 44(4):712\u2013721. https:\/\/doi.org\/10.1111\/ijlh.13829","journal-title":"Int J Lab Hematol"},{"issue":"7","key":"5234_CR69","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/s2352-3026(21)00105-8","volume":"8","author":"J Leentjens","year":"2021","unstructured":"Leentjens J, van Haaps TF, Wessels PF, Schutgens REG, Middeldorp S (2021) COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol 8(7):e524\u2013e533. https:\/\/doi.org\/10.1016\/s2352-3026(21)00105-8","journal-title":"Lancet Haematol"},{"issue":"1","key":"5234_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/ijlh.13329","volume":"43","author":"D White","year":"2021","unstructured":"White D, MacDonald S, Edwards T et al (2021) Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays. Int J Lab Hematol 43(1):123\u2013130. https:\/\/doi.org\/10.1111\/ijlh.13329","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"5234_CR71","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1160\/th12-04-0273","volume":"108","author":"RJ Fish","year":"2012","unstructured":"Fish RJ, Neerman-Arbez M (2012) Fibrinogen gene regulation. Thromb Haemost 108(3):419\u2013426. https:\/\/doi.org\/10.1160\/th12-04-0273","journal-title":"Thromb Haemost"},{"issue":"7","key":"5234_CR72","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"M Ranucci","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 18(7):1747\u20131751. https:\/\/doi.org\/10.1111\/jth.14854","journal-title":"J Thromb Haemost"},{"key":"5234_CR73","doi-asserted-by":"publisher","unstructured":"Polimeni A, Leo I, Spaccarotella C et al (2021) Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients. Sci Rep, 11 (1):10464. https:\/\/doi.org\/https:\/\/doi.org\/10.1038\/s41598-021-89967-x","DOI":"10.1038\/s41598-021-89967-x"},{"issue":"22","key":"5234_CR74","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","volume":"120","author":"T Renn\u00e9","year":"2012","unstructured":"Renn\u00e9 T, Schmaier AH, Nickel KF, Blomb\u00e4ck M, Maas C (2012) In vivo roles of factor XII. Blood 120(22):4296\u20134303. https:\/\/doi.org\/10.1182\/blood-2012-07-292094","journal-title":"Blood"},{"issue":"4","key":"5234_CR75","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1182\/blood-2008-07-171066","volume":"114","author":"PE van der Meijden","year":"2009","unstructured":"van der Meijden PE, Munnix IC, Auger JM et al (2009) Dual role of collagen in factor XII-dependent thrombus formation. Blood 114(4):881\u2013890. https:\/\/doi.org\/10.1182\/blood-2008-07-171066","journal-title":"Blood"},{"issue":"9","key":"5234_CR76","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1161\/atvbaha.114.304114","volume":"34","author":"TJ Gould","year":"2014","unstructured":"Gould TJ, Vu TT, Swystun LL, Dwivedi DJ, Mai SH, Weitz JI, Liaw PC (2014) Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol 34(9):1977\u20131984. https:\/\/doi.org\/10.1161\/atvbaha.114.304114","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"5234_CR77","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00277-020-04366-y","volume":"100","author":"MS Rahi","year":"2021","unstructured":"Rahi MS, Jindal V, Reyes S-P, Gunasekaran K, Gupta R, Jaiyesimi I (2021) Hematologic disorders associated with COVID-19: a review. Ann Hematol 100(2):309\u2013320. https:\/\/doi.org\/10.1007\/s00277-020-04366-y","journal-title":"Ann Hematol"},{"key":"5234_CR78","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.ebiom.2021.103382","volume":"67","author":"H Englert","year":"2021","unstructured":"Englert H, Rangaswamy C, Deppermann C et al (2021) Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 67:103382. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103382","journal-title":"EBioMedicine"},{"issue":"6","key":"5234_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.blre.2016.06.002","volume":"30","author":"A Dorgalaleh","year":"2016","unstructured":"Dorgalaleh A, Rashidpanah J (2016) Blood coagulation factor XIII and factor XIII deficiency. Blood Rev 30(6):461\u2013475. https:\/\/doi.org\/10.1016\/j.blre.2016.06.002","journal-title":"Blood Rev"},{"issue":"12","key":"5234_CR80","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1055\/a-1450-8414","volume":"121","author":"FA von Meijenfeldt","year":"2021","unstructured":"von Meijenfeldt FA, Havervall S, Adelmeijer J et al (2021) COVID-19 is associated with an acquired factor XIII deficiency. Thromb Haemost 121(12):1668\u20131669","journal-title":"Thromb Haemost"},{"issue":"17","key":"5234_CR81","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1177\/15353702221102117","volume":"247","author":"A Gupta","year":"2022","unstructured":"Gupta A, Qaisar R, Halwani R, Kannan M, Ahmad F (2022) TFPI and FXIII negatively and S100A8\/A9 and cystatin C positively correlate with D-dimer in COVID-19. Exp Biol Med (Maywood) 247(17):1570\u20131576. https:\/\/doi.org\/10.1177\/15353702221102117","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"5234_CR82","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","volume":"231","author":"FL Wright","year":"2020","unstructured":"Wright FL, Vogler TO, Moore EE et al (2020) Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. J Am Coll Surg 231(2):193\u2013203.e191. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.05.007","journal-title":"J Am Coll Surg"},{"issue":"3","key":"5234_CR83","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/aln.0000000000003685","volume":"134","author":"C Heinz","year":"2021","unstructured":"Heinz C, Miesbach W, Herrmann E et al (2021) Greater fibrinolysis resistance but no greater platelet aggregation in critically ill COVID-19 patients. Anesthesiology 134(3):457\u2013467. https:\/\/doi.org\/10.1097\/aln.0000000000003685","journal-title":"Anesthesiology"},{"issue":"6","key":"5234_CR84","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/jth.15327","volume":"19","author":"GK Juneja","year":"2021","unstructured":"Juneja GK, Castelo M, Yeh CH et al (2021) Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: a single-center prospective longitudinal study. J Thromb Haemost 19(6):1546\u20131557. https:\/\/doi.org\/10.1111\/jth.15327","journal-title":"J Thromb Haemost"},{"issue":"7","key":"5234_CR85","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1055\/s-0040-1709996","volume":"46","author":"HC Kwaan","year":"2020","unstructured":"Kwaan HC (2020) Coronavirus disease 2019: the role of the fibrinolytic system from transmission to organ injury and sequelae. Semin Thromb Hemost 46(7):841\u2013844. https:\/\/doi.org\/10.1055\/s-0040-1709996","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"5234_CR86","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1055\/s-0040-1715454","volume":"46","author":"BM Henry","year":"2020","unstructured":"Henry BM, Benoit SW, Hoehn J, Lippi G, Favaloro EJ, Benoit JL (2020) Circulating plasminogen concentration at admission in patients with coronavirus disease 2019 (COVID-19). Semin Thromb Hemost 46(07):859\u2013862","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"5234_CR87","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1055\/a-1400-6034","volume":"121","author":"S Hammer","year":"2021","unstructured":"Hammer S, H\u00e4berle H, Schlensak C et al (2021) Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: a descriptive study of fibrinolysis in COVID-19. Thromb Haemost 121(11):1417\u20131426. https:\/\/doi.org\/10.1055\/a-1400-6034","journal-title":"Thromb Haemost"},{"issue":"9","key":"5234_CR88","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/jth.15016","volume":"18","author":"C Nougier","year":"2020","unstructured":"Nougier C, Benoit R, Simon M et al (2020) Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost 18(9):2215\u20132219. https:\/\/doi.org\/10.1111\/jth.15016","journal-title":"J Thromb Haemost"},{"key":"5234_CR89","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.eclinm.2021.101069","volume":"39","author":"IMB Francischetti","year":"2021","unstructured":"Francischetti IMB, Toomer K, Zhang Y et al (2021) Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. EClinicalMedicine 39:101069. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101069","journal-title":"EClinicalMedicine"},{"issue":"7","key":"5234_CR90","doi-asserted-by":"publisher","first-page":"e01236","DOI":"10.1213\/xaa.0000000000001236","volume":"14","author":"A Tabatabai","year":"2020","unstructured":"Tabatabai A, Rabin J, Menaker J et al (2020) Factor VIII and functional protein C activity in critically ill patients with coronavirus disease 2019: a case series. A A Pract 14(7):e01236. https:\/\/doi.org\/10.1213\/xaa.0000000000001236","journal-title":"A A Pract"},{"issue":"12","key":"5234_CR91","doi-asserted-by":"publisher","first-page":"e0243604","DOI":"10.1371\/journal.pone.0243604","volume":"15","author":"TD Corr\u00eaa","year":"2020","unstructured":"Corr\u00eaa TD, Cordioli RL, Campos Guerra JC et al (2020) Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study. PLoS One 15(12):e0243604. https:\/\/doi.org\/10.1371\/journal.pone.0243604","journal-title":"PLoS One"},{"issue":"8","key":"5234_CR92","doi-asserted-by":"publisher","first-page":"e17463","DOI":"10.7759\/cureus.17463","volume":"13","author":"T Sehgal","year":"2021","unstructured":"Sehgal T, Gupta N, Kohli S et al (2021) A prospective study of specialized coagulation parameters in admitted COVID-19 patients and their correlation with acute respiratory distress syndrome and outcome. Cureus 13(8):e17463. https:\/\/doi.org\/10.7759\/cureus.17463","journal-title":"Cureus"},{"issue":"12","key":"5234_CR93","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1055\/s-0040-1716544","volume":"120","author":"GT Gerotziafas","year":"2020","unstructured":"Gerotziafas GT, Sergentanis TN, Voiriot G et al (2020) Derivation and validation of a predictive score for disease worsening in patients with COVID-19. Thromb Haemost 120(12):1680\u20131690. https:\/\/doi.org\/10.1055\/s-0040-1716544","journal-title":"Thromb Haemost"},{"key":"5234_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.thromres.2021.05.016","volume":"204","author":"TM Stanne","year":"2021","unstructured":"Stanne TM, Pedersen A, Gissl\u00e9n M, Jern C (2021) Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 204:13\u201315. https:\/\/doi.org\/10.1016\/j.thromres.2021.05.016","journal-title":"Thromb Res"},{"key":"5234_CR95","doi-asserted-by":"publisher","first-page":"103812","DOI":"10.1016\/j.ebiom.2022.103812","volume":"75","author":"T Won","year":"2022","unstructured":"Won T, Wood MK, Hughes DM et al (2022) Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine 75:103812. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103812","journal-title":"EBioMedicine"},{"issue":"12","key":"5234_CR96","doi-asserted-by":"publisher","first-page":"e0588","DOI":"10.1097\/cce.0000000000000588","volume":"3","author":"E Cani","year":"2021","unstructured":"Cani E, Dwivedi DJ, Liaw KL et al (2021) Immunothrombosis biomarkers for distinguishing coronavirus disease 2019 patients from noncoronavirus disease septic patients with pneumonia and for predicting ICU Mortality. Crit Care Explor 3(12):e0588. https:\/\/doi.org\/10.1097\/cce.0000000000000588","journal-title":"Crit Care Explor"},{"issue":"2","key":"5234_CR97","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0049-3848(98)00200-x","volume":"94","author":"Y L\u00f3pez-Aguirre","year":"1999","unstructured":"L\u00f3pez-Aguirre Y, P\u00e1ramo JA (1999) Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. Thromb Res 94(2):95\u2013101. https:\/\/doi.org\/10.1016\/s0049-3848(98)00200-x","journal-title":"Thromb Res"},{"issue":"5","key":"5234_CR98","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/shk.0000000000001780","volume":"56","author":"AG Vassiliou","year":"2021","unstructured":"Vassiliou AG, Keskinidou C, Jahaj E et al (2021) Could soluble endothelial protein C receptor levels recognize SARS-CoV2-positive patients requiring hospitalization? Shock 56(5):733\u2013736. https:\/\/doi.org\/10.1097\/shk.0000000000001780","journal-title":"Shock"},{"issue":"8","key":"5234_CR99","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1074\/jbc.275.8.5447","volume":"275","author":"PC Liaw","year":"2000","unstructured":"Liaw PC, Neuenschwander PF, Smirnov MD, Esmon CT (2000) Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 275(8):5447\u20135452. https:\/\/doi.org\/10.1074\/jbc.275.8.5447","journal-title":"J Biol Chem"},{"issue":"8","key":"5234_CR100","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/mbc.0000000000001070","volume":"32","author":"N Bayrakci","year":"2021","unstructured":"Bayrakci N, Ozkan G, Mutlu LC, Erdem L, Yildirim I, Gulen D, Celikkol A (2021) Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings. Blood Coagul Fibrinolysis 32(8):550\u2013555. https:\/\/doi.org\/10.1097\/mbc.0000000000001070","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"5234_CR101","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R, Liu F, Wu KL, Li J, Liu XH, Zhu CL (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 58(7):1116\u20131120. https:\/\/doi.org\/10.1515\/cclm-2020-0188","journal-title":"Clin Chem Lab Med"},{"issue":"10236","key":"5234_CR102","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/s0140-6736(20)31041-2","volume":"395","author":"O Gross","year":"2020","unstructured":"Gross O, Moerer O, Weber M, Huber TB, Scheithauer S (2020) COVID-19-associated nephritis: early warning for disease severity and complications? Lancet 395(10236):e87\u2013e88. https:\/\/doi.org\/10.1016\/s0140-6736(20)31041-2","journal-title":"Lancet"},{"key":"5234_CR103","doi-asserted-by":"publisher","first-page":"575047","DOI":"10.3389\/fimmu.2020.575047","volume":"11","author":"B Buijsers","year":"2020","unstructured":"Buijsers B, Yanginlar C, de Nooijer A et al (2020) Increased plasma heparanase activity in COVID-19 patients. Front Immunol 11:575047. https:\/\/doi.org\/10.3389\/fimmu.2020.575047","journal-title":"Front Immunol"},{"issue":"3","key":"5234_CR104","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0749-0704(03)00008-3","volume":"19","author":"M Nimah","year":"2003","unstructured":"Nimah M, Brilli RJ (2003) Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 19(3):441\u2013458. https:\/\/doi.org\/10.1016\/s0749-0704(03)00008-3","journal-title":"Crit Care Clin"},{"issue":"11","key":"5234_CR105","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.numecd.2020.07.040","volume":"30","author":"C Gazzaruso","year":"2020","unstructured":"Gazzaruso C, Paolozzi E, Valenti C et al (2020) Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. Nutr Metab Cardiovasc Dis 30(11):1914\u20131919. https:\/\/doi.org\/10.1016\/j.numecd.2020.07.040","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"5234_CR106","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4274\/tjh.galenos.2021.2020.0695","volume":"38","author":"\u0130 Anakl\u0131","year":"2021","unstructured":"Anakl\u0131 \u0130, Ergin \u00d6zcan P, Polat \u00d6 et al (2021) Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: a retrospective study. Turk J Haematol 38(1):15\u201321. https:\/\/doi.org\/10.4274\/tjh.galenos.2021.2020.0695","journal-title":"Turk J Haematol"},{"key":"5234_CR107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2022.03.013","volume":"213","author":"N Bokn\u00e4s","year":"2022","unstructured":"Bokn\u00e4s N, Laine C, Hillarp A, Macwan AS, Gustafsson KM, Lindahl TL, Holmstr\u00f6m M (2022) Associations between hemostatic markers and mortality in COVID-19 - compounding effects of D-dimer, antithrombin and PAP complex. Thromb Res 213:97\u2013104. https:\/\/doi.org\/10.1016\/j.thromres.2022.03.013","journal-title":"Thromb Res"},{"issue":"04","key":"5234_CR108","first-page":"460","volume":"47","author":"G Lippi","year":"2020","unstructured":"Lippi G, Henry BM, Sanchis-Gomar F (2020) Plasma antithrombin values are significantly decreased in coronavirus disease 2019 (COVID-19) patients with severe illness. Semin Thromb Hemost 47(04):460\u2013462","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"5234_CR109","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/17474086.2022.2104708","volume":"15","author":"M Rostami","year":"2022","unstructured":"Rostami M, Mansouritorghabeh H (2022) Trend of fluctuations of antithrombin in plasma of patients with COVID-19: a meta-analysis and systematic review. Expert Rev Hematol 15(8):747\u2013755. https:\/\/doi.org\/10.1080\/17474086.2022.2104708","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"5234_CR110","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2353\/ajpath.2007.070104","volume":"171","author":"H Tang","year":"2007","unstructured":"Tang H, Ivanciu L, Popescu N et al (2007) Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. Am J Pathol 171(3):1066\u20131077. https:\/\/doi.org\/10.2353\/ajpath.2007.070104","journal-title":"Am J Pathol"},{"issue":"2","key":"5234_CR111","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/tjh.2014.0312","volume":"33","author":"HA Al Otair","year":"2016","unstructured":"Al Otair HA, Abdel Gader AG, Khurshid SM et al (2016) The levels of tissue factor pathway inhibitor in sepsis patients receiving prophylactic enoxaparin. Turk J Haematol 33(2):112\u2013118. https:\/\/doi.org\/10.4274\/tjh.2014.0312","journal-title":"Turk J Haematol"},{"issue":"2","key":"5234_CR112","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11239-021-02583-4","volume":"53","author":"R Cacciola","year":"2022","unstructured":"Cacciola R, Gentilini Cacciola E, Vecchio V, Cacciola E (2022) Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy. J Thromb Thromb 53(2):282\u2013290. https:\/\/doi.org\/10.1007\/s11239-021-02583-4","journal-title":"J Thromb Thromb"},{"issue":"4","key":"5234_CR113","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/jth.15660","volume":"20","author":"S Kelliher","year":"2022","unstructured":"Kelliher S, Weiss L, Cullivan S et al (2022) Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis. J Thromb Haemost 20(4):1008\u20131014. https:\/\/doi.org\/10.1111\/jth.15660","journal-title":"J Thromb Haemost"},{"issue":"5","key":"5234_CR114","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/ATVBAHA.120.315595","volume":"41","author":"A Dupont","year":"2021","unstructured":"Dupont A, Rauch A, Staessens S et al (2021) Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler Thromb Vasc Biol 41(5):1760\u20131773. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315595","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5234_CR115","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","volume":"15","author":"JW Yau","year":"2015","unstructured":"Yau JW, Teoh H, Verma S (2015) Endothelial cell control of thrombosis. BMC Cardiovasc Disord 15:130. https:\/\/doi.org\/10.1186\/s12872-015-0124-z","journal-title":"BMC Cardiovasc Disord"},{"key":"5234_CR116","volume-title":"Henry's clinical diagnosis and management by laboratory methods","author":"RA McPherson","year":"2021","unstructured":"McPherson RA, Pincus MR (2021) Henry's clinical diagnosis and management by laboratory methods, 4th edn. Elsevier, Philadelphia","edition":"24. edn."},{"key":"5234_CR117","doi-asserted-by":"publisher","unstructured":"Gralinski LE, Bankhead A 3rd, Jeng S et al (2013) Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio 4(4). https:\/\/doi.org\/10.1128\/mBio.00271-13","DOI":"10.1128\/mBio.00271-13"},{"issue":"10234","key":"5234_CR118","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/s0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417\u20131418. https:\/\/doi.org\/10.1016\/s0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"5234_CR119","volume-title":"Thrombosis and COVID-19 pneumonia: the clot thickens","author":"LC Price","year":"2020","unstructured":"Price LC, McCabe C, Garfield B, Wort SJ (2020) Thrombosis and COVID-19 pneumonia: the clot thickens, vol 56. Eur Respiratory Soc"},{"issue":"11","key":"5234_CR120","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/infdis\/jiaa528","volume":"222","author":"C Guervilly","year":"2020","unstructured":"Guervilly C, Burtey S, Sabatier F et al (2020) Circulating endothelial cells as a marker of endothelial injury in severe COVID -19. J Infect Dis 222(11):1789\u20131793. https:\/\/doi.org\/10.1093\/infdis\/jiaa528","journal-title":"J Infect Dis"},{"key":"5234_CR121","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.blre.2020.100761","volume":"47","author":"T Hadid","year":"2021","unstructured":"Hadid T, Kafri Z, Al-Katib A (2021) Coagulation and anticoagulation in COVID-19. Blood Rev 47:100761. https:\/\/doi.org\/10.1016\/j.blre.2020.100761","journal-title":"Blood Rev"},{"issue":"10","key":"5234_CR122","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41577-022-00762-9","volume":"22","author":"EM Conway","year":"2022","unstructured":"Conway EM, Mackman N, Warren RQ et al (2022) Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 22(10):639\u2013649. https:\/\/doi.org\/10.1038\/s41577-022-00762-9","journal-title":"Nat Rev Immunol"},{"key":"5234_CR123","doi-asserted-by":"publisher","unstructured":"Luo W-R, Yu H, Gou J-Z et al (2020) Histopathologic findings in the explant lungs of a patient with COVID-19 treated with bilateral orthotopic lung transplant. Transplantation 104(11):329\u2013331. https:\/\/doi.org\/10.1097\/tp.0000000000003412","DOI":"10.1097\/tp.0000000000003412"},{"issue":"1","key":"5234_CR124","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ajpath.2021.09.004","volume":"192","author":"JE Johnson","year":"2022","unstructured":"Johnson JE, McGuone D, Xu ML, Jane-Wit D, Mitchell RN, Libby P, Pober JS (2022) Coronavirus disease 2019 (COVID-19) coronary vascular thrombosis: correlation with neutrophil but not endothelial activation. Am J Pathol 192(1):112\u2013120","journal-title":"Am J Pathol"},{"issue":"6","key":"5234_CR125","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00134-020-06057-8","volume":"46","author":"M-C Copin","year":"2020","unstructured":"Copin M-C, Parmentier E, Duburcq T, Poissy J, Mathieu D (2020) Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med 46(6):1124\u20131126","journal-title":"Intensive Care Med"},{"issue":"1","key":"5234_CR126","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","volume":"98","author":"H Su","year":"2020","unstructured":"Su H, Yang M, Wan C et al (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219\u2013227","journal-title":"Kidney Int"},{"key":"5234_CR127","doi-asserted-by":"publisher","first-page":"e64909","DOI":"10.7554\/eLife.64909","volume":"10","author":"FW Chioh","year":"2021","unstructured":"Chioh FW, Fong S-W, Young BE et al (2021) Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife 10:e64909","journal-title":"Elife"},{"issue":"1","key":"5234_CR128","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0008-6363(03)00354-7","volume":"60","author":"TT Keller","year":"2003","unstructured":"Keller TT, Mairuhu AT, de Kruif MD et al (2003) Infections and endothelial cells. Cardiovasc Res 60(1):40\u201348","journal-title":"Cardiovasc Res"},{"key":"5234_CR129","doi-asserted-by":"publisher","unstructured":"Otifi HM, Adiga BK (2022) Endothelial dysfunction in Covid-19 infection. Am J Med Sci 363 (4):281\u2013287. https:\/\/doi.org\/10.1016\/j.amjms.2021.12.010","DOI":"10.1016\/j.amjms.2021.12.010"},{"key":"5234_CR130","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.blre.2022.100995","volume":"57","author":"EHT Lim","year":"2023","unstructured":"Lim EHT, van Amstel RBE, de Boer VV et al (2023) Complement activation in COVID-19 and targeted therapeutic options: a scoping review. Blood Rev 57:100995. https:\/\/doi.org\/10.1016\/j.blre.2022.100995","journal-title":"Blood Rev"},{"issue":"5","key":"5234_CR131","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/moh.0000000000000605","volume":"27","author":"S Oncul","year":"2020","unstructured":"Oncul S, Afshar-Kharghan V (2020) The interaction between the complement system and hemostatic factors. Curr Opin Hematol 27(5):341\u2013352. https:\/\/doi.org\/10.1097\/moh.0000000000000605","journal-title":"Curr Opin Hematol"},{"key":"5234_CR132","doi-asserted-by":"publisher","unstructured":"Yan B, Freiwald T, Chauss D et al (2021) SARS-CoV-2 drives JAK1\/2-dependent local complement hyperactivation. Sci Immunol 6(58). https:\/\/doi.org\/10.1126\/sciimmunol.abg0833","DOI":"10.1126\/sciimmunol.abg0833"},{"issue":"40","key":"5234_CR133","doi-asserted-by":"publisher","first-page":"25018","DOI":"10.1073\/pnas.2010540117","volume":"117","author":"JC Holter","year":"2020","unstructured":"Holter JC, Pischke SE, de Boer E et al (2020) Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci U S A 117(40):25018\u201325025. https:\/\/doi.org\/10.1073\/pnas.2010540117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7836","key":"5234_CR134","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","volume":"588","author":"J Carvelli","year":"2020","unstructured":"Carvelli J, Demaria O, Vely F et al (2020) Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature 588(7836):146\u2013150. https:\/\/doi.org\/10.1038\/s41586-020-2600-6","journal-title":"Nature"},{"key":"5234_CR135","doi-asserted-by":"publisher","first-page":"663187","DOI":"10.3389\/fimmu.2021.663187","volume":"12","author":"G Sinkovits","year":"2021","unstructured":"Sinkovits G, Mezo B, Reti M et al (2021) Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front Immunol 12:663187. https:\/\/doi.org\/10.3389\/fimmu.2021.663187","journal-title":"Front Immunol"},{"key":"5234_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Trans Res 220:1\u201313. https:\/\/doi.org\/10.1016\/j.trsl.2020.04.007","journal-title":"Trans Res"},{"issue":"10","key":"5234_CR137","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","volume":"143","author":"D Pellegrini","year":"2021","unstructured":"Pellegrini D, Kawakami R, Guagliumi G et al (2021) Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation 143(10):1031\u20131042. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051828","journal-title":"Circulation"},{"key":"5234_CR138","doi-asserted-by":"publisher","first-page":"827146","DOI":"10.3389\/fimmu.2022.827146","volume":"13","author":"L Perico","year":"2022","unstructured":"Perico L, Morigi M, Galbusera M et al (2022) SARS-CoV-2 spike protein 1 activates microvascular endothelial cells and complement system leading to platelet aggregation. Front Immunol 13:827146. https:\/\/doi.org\/10.3389\/fimmu.2022.827146","journal-title":"Front Immunol"},{"issue":"3","key":"5234_CR139","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MBC.0b013e3280116c84","volume":"18","author":"RA Marlar","year":"2007","unstructured":"Marlar RA, Potts RM, Welsh CH (2007) A systems biology approach to the diagnosis of venous thrombosis risk. Blood Coagul Fibrinolysis 18(3):215\u2013217. https:\/\/doi.org\/10.1097\/MBC.0b013e3280116c84","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05234-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05234-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:18:28Z","timestamp":1683872308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05234-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":139,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5234"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05234-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"17 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee at the Arak University of Medical Sciences (No. IR.ARAKMU.REC.1401.223). This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}